Article
Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Journal of pediatric hematology/oncology - 1 Oct 2020
Myint Htar H, Tandon Sneha, Narula Gaurav, Prasad Maya, Subramanian Papagudi, Patkar Nikhil, Tembhare Prashant, Gujral Sumeet, Banavali Shripad
Abstract excerpt
INTRODUCTION: Mixed-phenotype acute leukemia (MPAL) accounts for 1.2% to 5% of acute leukemia across age groups with intermediate prognosis. We evaluated clinicoepidemiologic profiles and outcomes of MPAL. METHODS: Records of children younger than 15 years of age with acute leukemia from January 2010 to December 2016 were reviewed on the basis of the MPAL WHO 2008 criteria. Treatment was uniform with a modified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
